Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nestel

Showing results (551-560 of 588) with videos related to

Pageof 59
Sort By:
Diabetes|June 6, 2012
Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjectsNora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2015
Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndromeNora E Straznicky, Mariee T Grima, Elisabeth A Lambert, et al.
The American Journal of Clinical Nutrition|December 6, 2008
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndromeNora E Straznicky, Gavin W Lambert, Kazuko Masuo, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndromeNora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
Diabetes, Obesity & Metabolism|September 20, 2011
The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjectsN E Straznicky, E A Lambert, M T Grima, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2012
The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndromeNora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2011
Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjectsNora E Straznicky, Nina Eikelis, Paul J Nestel, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 27, 2010
Survey of access to gastroenterology in Canada: the SAGE wait times programDesmond Leddin, Ronald J Bridges, David G Morgan, et al.
European Heart Journal|February 26, 2008
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID studyMalcolm J West, Paul J Nestel, Adrienne C Kirby, et al.
Lancet (London, England)|October 9, 2018
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trialsPeter Willeit, Paul M Ridker, Paul J Nestel, et al.
Pageof 59

Showing results (551-560 of 588) with videos related to

Sort By:
Pageof 59
Diabetes|June 6, 2012
Neuroadrenergic dysfunction along the diabetes continuum: a comparative study in obese metabolic syndrome subjectsNora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
The Journal of Clinical Endocrinology and Metabolism|January 16, 2015
Arterial norepinephrine concentration is inversely and independently associated with insulin clearance in obese individuals with metabolic syndromeNora E Straznicky, Mariee T Grima, Elisabeth A Lambert, et al.
The American Journal of Clinical Nutrition|December 6, 2008
Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndromeNora E Straznicky, Gavin W Lambert, Kazuko Masuo, et al.
The Journal of Clinical Endocrinology and Metabolism|June 18, 2014
A randomized controlled trial of the effects of pioglitazone treatment on sympathetic nervous system activity and cardiovascular function in obese subjects with metabolic syndromeNora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
Diabetes, Obesity & Metabolism|September 20, 2011
The effects of dietary weight loss with or without exercise training on liver enzymes in obese metabolic syndrome subjectsN E Straznicky, E A Lambert, M T Grima, et al.
The Journal of Clinical Endocrinology and Metabolism|December 29, 2012
The relation of glucose metabolism to left ventricular mass and function and sympathetic nervous system activity in obese subjects with metabolic syndromeNora E Straznicky, Mariee T Grima, Carolina I Sari, et al.
The Journal of Clinical Endocrinology and Metabolism|November 18, 2011
Baseline sympathetic nervous system activity predicts dietary weight loss in obese metabolic syndrome subjectsNora E Straznicky, Nina Eikelis, Paul J Nestel, et al.
Canadian Journal of Gastroenterology = Journal Canadien De Gastroenterologie|February 27, 2010
Survey of access to gastroenterology in Canada: the SAGE wait times programDesmond Leddin, Ronald J Bridges, David G Morgan, et al.
European Heart Journal|February 26, 2008
The value of N-terminal fragment of brain natriuretic peptide and tissue inhibitor of metalloproteinase-1 levels as predictors of cardiovascular outcome in the LIPID studyMalcolm J West, Paul J Nestel, Adrienne C Kirby, et al.
Lancet (London, England)|October 9, 2018
Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trialsPeter Willeit, Paul M Ridker, Paul J Nestel, et al.
Pageof 59